PHESGO

Solution for injection, (600mg + 600mg)/10ml
RxActive license

Active substance (INN)

pertuzumab and trastuzumab

Pharmaceutical form

Pharmaceutical formSolution for injection
Strength(600mg + 600mg)/10ml
PackagingUkupno jedna bočica staklena sa 10ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF.Hoffmann-La Roche Ltd., Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FY01)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateDecember 14, 2021

Analogs in Montenegro

1

Other medicines with the same active substance

Source: CInMED register